By 
Elon Musk‘s startup Neuralink Corp. should be ready to test its technology on humans in six months, the entrepreneur said Wednesday during a live-streamed update about progress the company has made with its brain-implant technology.
Neuralink has submitted most of its paperwork to the U.S. Food and Drug Administration, which oversees medical devices, including neural implants, Musk said. In 2019, he said the company planned to seek the FDA’s approval for human testing and predicted it could begin as soon as 2020.
The company wants to be able to help restore vision and enable people with severe disabilities to move and communicate by decoding brain activity. Eventually, Neuralink wants to open clinics where patients could get a device implanted into their brains by their surgical robots, which the company also showcased at the Wednesday event.
Musk showed a video of “telepathic typing” from a monkey that has a Neuralink brain implant. The animal was not typing into a keyboard but was able to move a cursor to images of letters.
An expanded version of this report appears on WSJ.com.
Also popular on WSJ.com:
The hotel inside the Bass Pro Shops inside the Pyramid.
Early Alameda staffers quit after battling Sam Bankman-Fried over risk, compliance concerns.
Comments